Accenture Acquires Bionest to Expand Life Sciences Strategy Capabilities

February 2, 2023

Accenture has acquired Bionest, a New York–based strategy and consulting firm focused on life sciences, bringing Bionest's 46 consultants into Accenture Strategy to bolster its Life Sciences practice. The acquisition expands Accenture's capabilities across precision medicine, diagnostics, oncology, cell & gene therapy, and rare diseases; terms were not disclosed.

Buyers
Accenture
Targets
Bionest
Location
New York, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.